Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A0KFRJ1
Fri, 03.02.2023       bioXXmed AG
DE000A0KFRJ1

Centaur Pharmaceuticals Pvt Ltd increases sales with Woxheal® - ongoing open label marketing study in numerous Indian centres Darmstadt, 2nd February, 2023 - The Management Board of bioXXmed AG and Centaur Pharmaceuticals created a new basis for future cooperation between the two companies during a visit of Centaur in Mumbai. Centaur has increase [ … ]
Technical analysis
To the publication
Fri, 03.02.2023       bioXXmed AG
DE000A0KFRJ1

Centaur Pharmaceuticals Pvt Ltd increases sales with Woxheal® - ongoing open label marketing study in numerous Indian centres Darmstadt, 2nd February, 2023 - The Management Board of bioXXmed AG and Centaur Pharmaceuticals created a new basis for future cooperation between the two companies during a visit of Centaur in Mumbai. Centaur has increase [ … ]
Technical analysis
To the publication
Thu, 30.09.2021       CytoTools AG
DE000A0KFRJ1

Annual General Meeting of CytoTools AG votes for dismissal of all Supervisory Board members Darmstadt, 30 September 2021 - CytoTools AG (ISIN DE000A0KFRJ1), a biotechnology holding company specializing in pharmaceutical and medical products, today held its Annual General Meeting in virtual form. Of the company's share capital of EUR 4,028,000.00,  [ … ]
Technical analysis
To the publication
Thu, 30.09.2021       CytoTools AG
DE000A0KFRJ1

Supervisory Board of CytoTools AG announces the retirement of the two members of the Management Board according to schedule - Management Board members Dr. Freyberg and Dr. Kaiser not available for contract extensions after being voted out of office by the Supervisory Board - Management Board contracts expire by rotation today Darmstadt, 30 Septem [ … ]
Technical analysis
To the publication
Wed, 29.09.2021       CytoTools AG
DE000A0KFRJ1

CytoTools Reports Progress of DermaPro(R) Phase III Study in Europe and Provides Operational Status Update - Good progress in patient recruitment for Phase III study despite unforeseen delays due to COVID-19 - Sales of Woxheal(R) gaining significant momentum since September - Further development steps of DPOCL inhalation therapy suspended as a prec [ … ]
Technical analysis
To the publication
Tue, 29.06.2021       CytoTools AG
DE000A0KFRJ1

CytoTools cures resolution of 2020 Annual General Meeting with proposed capital increase - Resolution on added items to the 2020 agenda proved to be unfeasible from a technical point of view - Proposal to the 2021 Annual General Meeting is essentially the same as the resolution adopted in 2020 Darmstadt, 29 June 2021 - CytoTools AG (ISIN DE000A0KF [ … ]
Technical analysis
To the publication
Mon, 21.06.2021       CytoTools AG
DE000A0KFRJ1

CytoTools Q1 Trading Update: Treatment numbers in India slightly above previous quarter despite significant pandemic impact - Over 10,000 use cases in Q1 despite tough lockdown in India - Expansion into Africa following provisional approval of Woxheal in Kenya Darmstadt, 21 June 2021 - CytoTools AG (ISIN DE000A0KFRJ1), a biotechnology holding comp [ … ]
Technical analysis
To the publication
Mon, 26.04.2021       CytoTools AG
DE000A0KFRJ1

CytoTools signs collaboration agreement to develop inhalation therapy for viral infections such as COVID-19 and influenza - Cooperation with medical technology specialists for inhalative applications - Regulatory approval with early out-licensing targeted - Completion of further development steps planned by end of third quarter Darmstadt, 26 April [ … ]
Technical analysis
To the publication
Mon, 21.12.2020       CytoTools AG
DE000A0KFRJ1

CytoTools receives confirmation of efficacy of DPCOL also against influenza viruses - Virus-killing effect of DPOCL also confirmed with regard to influenza viruses - Novel therapeutic approach thus also of high commercial interest beyond Corona pandemic - Final results report on Sars-CoV-2 virus confirms efficacy of more than 95 percent Darmstadt, [ … ]
Technical analysis
To the publication
Mon, 07.12.2020       CytoTools AG
DE000A0KFRJ1

Supervisory Board of CytoTools AG expresses trust in the Management Board after the Annual General Meeting - More than 98 percent of the shareholders represented support the company's current strategy - Shareholder group blocks large parts of the agenda with capital majority - Objection of two shareholders against capital measure significantly belo [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Thursday, 04.07.2024, Calendar Week 27, 186th day of the year, 180 days remaining until EoY.